18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Scanning Affects Surgical Management in Selected Patients With High-Risk, Operable Breast Carcinoma-Reference-Cited by-同舟云学术

18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Scanning Affects Surgical Management in Selected Patients With High-Risk, Operable Breast Carcinoma

Published:2006-03-16 Issue:5 Volume:13 Page:677-684
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Port Elisa Rush,Yeung Henry,Gonen Mithat,Liberman Laura,Caravelli James,Borgen Patrick,Larson Steven

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/ASO.2006.03.035.pdf

Reference18 articles.

1. Jemal A, Murray T, Ward E, et al. Cancer Statistics 2005. CA Cancer J Clin 2005; 55:10–30

2. Puglisi F, Follador A, Minisini AM, et al. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Ann Oncol 2005; 16:263–6

3. Samant R, Ganguly P. Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. Arch Surg 1999; 134:551–3; discussion 554

4. NCCN Practice Guidelines in Oncology, Vol 1. 2005

5. Warburg O. The Metabolism of Tumors. New York: Smith, 1931; 129–69

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer;Frontiers in Oncology;2020-08-12

2. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study;Clinical Breast Cancer;2017-12

3. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy;The Breast;2014-02

4. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer – Usefulness for malignant grade of triple-negative breast cancer;The Breast;2013-10

5. Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer;Expert Review of Anticancer Therapy;2013-03